ProCE Banner Activity

Personalized Treatment in Myelofibrosis: Applying the Data to Address Barriers and Improve Care


Download these slides from a live symposium featuring guidance from a clinical pharmacist and a specialty pharmacist on best practices for individualized management of patients with myelofibrosis, including evidence-based treatment options and the role of pharmacists in providing patient support, symptom and toxicity management, and monitoring.

Released: April 28, 2023



Emily Hollinghurst

Emily Hollinghurst, PharmD, BCOP, CSP, APh

Assistant Professor
Department of Pharmacy Practice
Loma Linda University, School of Pharmacy
Clinical Pharmacy Specialist
Specialty Pharmacy Services
Loma Linda University Medical Center
Loma Linda, California

Victoria Nachar

Victoria Nachar, PharmD, BCOP

Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC

ProCE Banner


This educational activity is supported by an educational grant from GSK .




Clinical Care Options, LLC

ProCE Banner